KALA BIO (KALA)
3.14
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form S-3/A KALA BIO, Inc.
June 12, 2026 4:06 PM - SEC Filing
Form SCHEDULE 13G/A KALA BIO, Inc. Filed by: BAKER BROS. ADVISORS LP
May 15, 2026 4:26 PM - SEC Filing
Form 10-Q KALA BIO, Inc. For: Mar 31
May 15, 2026 3:31 PM - SEC Filing
Form S-3 KALA BIO, Inc.
May 7, 2026 5:25 PM - SEC Filing
Form 8-K KALA BIO, Inc. For: May 07
May 7, 2026 4:09 PM - SEC Filing
KALA BIO implements 1-for-50 reverse stock split effective May 8
May 7, 2026 9:00 AM - StreetInsider
KALA BIO Announces Reverse Stock Split
May 7, 2026 9:00 AM - Globe NewsWire
Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments
April 28, 2026 8:00 AM - Globe NewsWire
Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine
April 21, 2026 7:00 AM - Globe NewsWire
Form 10-K KALA BIO, Inc. For: Dec 31
April 15, 2026 4:04 PM - SEC Filing
Kala Bio hires Dr. Saeid Babaei to review clinical assets
April 1, 2026 6:45 AM - StreetInsider
Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities
April 1, 2026 6:45 AM - StreetInsider
Form NT 10-K KALA BIO, Inc. For: Dec 31
March 31, 2026 4:06 PM - SEC Filing
KALA BIO launches commercial AI research platform for biotech
March 30, 2026 8:47 AM - StreetInsider
KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live
March 30, 2026 8:45 AM - StreetInsider
Full Article List
